Abstract
The Architect Syphilis TP is considered to be a suitable screening test due to its high sensitivity and full automation. According to the International Union against Sexually Transmitted Infections (IUSTI) 2014 guidelines, however, positive screening tests need confirmation with Treponema pallidum particle agglutination (TP.PA). Among Architect-positive results, samples with a negative non-treponemal test present the major diagnostic challenge. In this multicenter study, we investigated if other, preferable less labor-intensive treponemal tests could replace TP.PA. A total of 178 rapid plasma reagin (RPR)-negative sera with an Architect value between 1 and 15 S/CO were prospectively selected in three centers. These sera were analyzed with TP.PA and six alternative treponemal tests: three immunoblots and three tests on random-access analyzers. The diagnostic performance of the treponemal tests differed substantially, with the overall agreement between the six alternative tests ranging from 44.6 to 82.0 %. Based on TP.PA as the gold standard, the INNO-LIA IgG blot, the BioPlex 2200 IgG, and the Syphilis TPA showed a high sensitivity, while the EUROLINE-WB IgG blot, recomLine Treponema IgG blot, and the Chorus Syphilis screen showed a high specificity. However, an Architect cut-off of 5.6 S/CO can serve as an alternative for these confirmatory treponemal tests in case of an RPR-negative result. Treponemal tests show poor agreement in this challenging group of Architect-positive/RPR-negative sera. The most optimal algorithm is obtained by assigning sera with an Architect value >5.6 S/CO as true-positives and sera with a value between 1 and 5.6 S/CO as undetermined, requiring further testing with TP.PA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Apers L, Crucitti T, Verbrugge R, Vandenbruaene M (2012) Sexually transmitted infections: what’s new? Acta Clin Belg 67(3):154–159
Farhi D, Zizi N, Grange P, Benhaddou N, Gerhardt P, Avril MF, Dupin N (2009) The epidemiological and clinical presentation of syphilis in a venereal disease centre in Paris, France. A cohort study of 284 consecutive cases over the period 2000–2007. Eur J Dermatol 19(5):484–489
Fenton KA, Breban R, Vardavas R, Okano JT, Martin T, Aral S, Blower S (2008) Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 8(4):244–253
Read PJ, Donovan B (2012) Clinical aspects of adult syphilis. Intern Med J 42(6):614–620
Marangoni A, Moroni A, Accardo S, Cevenini R (2009) Laboratory diagnosis of syphilis with automated immunoassays. J Clin Lab Anal 23(1):1–6
Wellinghausen N, Dietenberger H (2011) Evaluation of two automated chemiluminescence immunoassays, the LIAISON Treponema Screen and the ARCHITECT Syphilis TP, and the Treponema pallidum particle agglutination test for laboratory diagnosis of syphilis. Clin Chem Lab Med 49(8):1375–1377
Young H, Pryde J, Duncan L, Dave J (2009) The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis. Sex Transm Infect 85(1):19–23
Lipinsky D, Schreiber L, Kopel V, Shainberg B (2012) Validation of reverse sequence screening for syphilis. J Clin Microbiol 50(4):1501
Janier M, Hegyi V, Dupin N, Unemo M, Tiplica GS, Potočnik M, French P, Patel R (2014) 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 28(12):1581–1593
Cole MJ, Perry KR, Parry JV (2007) Comparative evaluation of 15 serological assays for the detection of syphilis infection. Eur J Clin Microbiol Infect Dis 26(10):705–713
Binnicker MJ (2012) Which algorithm should be used to screen for syphilis? Curr Opin Infect Dis 25(1):79–85
Royal decree (2009) Koninklijk besluit tot vaststelling van de kwaliteits- en veiligheidsnormen voor het doneren, wegnemen, verkrijgen, testen, bewerken, bewaren en distribueren van menselijk lichaamsmateriaal, waarvan de banken voor menselijk lichaamsmateriaal, de intermediaire structuren voor menselijk lichaamsmateriaal en de productie-instellingen moeten voldoen. Belgisch Staatsblad
National guideline on prenatal care (2004) Nationale richtlijn prenatale zorg: een basis voor een klinisch pad voor de opvolging van zwangerschappen. KCE Reports vol. 6A
Lee K, Park H, Roh EY, Shin S, Park KU, Park MH, Song EY (2013) Characterization of sera with discordant results from reverse sequence screening for syphilis. Biomed Res Int 2013:269347
Binnicker MJ, Jespersen DJ, Rollins LO (2011) Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays. J Clin Microbiol 49(4):1313–1317
Alonso R, Reigadas E, Bunsow E, López-Roa P, Bouza Santiago E (2013) Establishment of a “grey zone” for the Architect Syphilis Assay (Abbott). Abstract presented at the 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Berlin, Germany, April 2013
De Carolis S, Santucci S, Botta A, Salvi S, Degennaro VA, Garufi C, Garofalo S, Ferrazzani S, Scambia G (2012) The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome. Lupus 21(7):773–775
Eichler R, Prostko J, Fischer C, Hausmann M, Christ H (2007) Evaluation of the new ARCHITECT Rubella IgM assay. J Clin Virol 39(3):182–187
Acosta J, Barrado L, Viedma E, Fuertes A (2011) Bioplex 2200, a new treponemic assay to diagnose syphilis. Abstract presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Milan, Italy, May 2011
Acknowledgments
The authors thank Mikrogen Diagnostik, Euroimmun, Fujirebio Europe N.V., Bio-Rad Laboratories, and Ortho-Clinical Diagnostics for donating test kits for this study.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jonckheere, S., Berth, M., Van Esbroeck, M. et al. Evaluation of different confirmatory algorithms using seven treponemal tests on Architect Syphilis TP-positive/RPR-negative sera. Eur J Clin Microbiol Infect Dis 34, 2041–2048 (2015). https://doi.org/10.1007/s10096-015-2449-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-015-2449-z